Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

22nd Annual International Congress on the Future of Breast Cancer® West

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Scott Tagawa, MD, MS, FACP; Alicia Morgans, MD, MPH; Michael J. Morris, MD

Medical Crossfire®: Key Questions on Sequencing, Radioligands, and Novel Emerging Approaches in CRPC

Narjust Duma, MD; Coral Olazagasti, MD; Gilberto de Lima Lopes, MD, MBA, FASCO; Ana Maria López, MD, MPH, MACP, FRCP;  Vonetta M. Williams, MD, PhD

Working Group™: Strategies for Recognizing and Taking Steps to Address Disparities in Cancer Care Among Diverse Populations

Robert L. Coleman, MD, FACOG, FACS; Ursula A. Matulonis, MD; Bradley J. Monk, MD, FACS, FACOG; Kathleen Moore, MD

Community Practice Connections™: 13th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Community Practice Connections™:  Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Sara A. Hurvitz, MD, FACP; Aditya Bardia, MD, MPH

Community Practice Connections™: Incorporating Novel HER2-Targeted Therapies Into Treatment Algorithms Across Metastatic Breast Cancer

Jessica Michaud Davis, PharmD, BCOP, CPP; Robert L. Ferris, MD, PhD; Kristi K Orbaugh, MSN, NP, AOCNP

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

24th Annual International Lung Cancer Congress®

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

James L.M. Ferrara, MD, DSc; Carrie L. Kitko, MD

Community Practice Connections™: Incorporating Novel Therapies Into Treatment Algorithms Across Acute and Chronic GVHD

Advanced Renal Cell Carcinoma: Tyrosine Kinase Inhibitors Versus Immune Checkpoint Inhibitors

Sandra Kurtin, PhD, ANP-BC, AOCN; Ravi Vij, MD, MBA; Kathryn Maples, PharmD, BCOP

Advances In: Interprofessional Strategies to Optimize Outcomes for Patients with Relapsed/Refractory Multiple Myeloma: Expert Discussions to Maximize Safety and Efficacy

Clement L. Ren, MD, MBA, ATSF; Samya Nasr, MD, CPI, ATSF; George M. Solomon, MD

Clinical Consultations™: Optimizing Treatment Outcomes for Patients With Cystic Fibrosis

BURST CME™: Exploring the Biologic Rationale for Novel IRAK4-directed Therapy for the Treatment of High Risk MDS and AML 

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Jeff Unger, MD, FAAFP, FACE;  Jennifer D. Goldman, PharmD, RPh, CDCES, BC-ADM, FCCP; Carrie McAdam-Marx, PhD, RPh; Brittany Hoffmann-Eubanks, PharmD, MBA; Angel A. Rodriguez, PharmD; Lori A. Uildriks, PharmD, BCPS, BCGP; Jeannette Y. Wick, RPh, MBA, FASCP

Analyzing the Value of Continuous Glucose Monitoring in Diabetes Care and Overcoming Barriers Through Expanded Pharmacy Access

Caring for Patients on CAR T-Cell Therapy in the Inpatient Versus Outpatient Setting

Advances In™: The Role of NRG1 Fusions Across Tumor Types

Tiffany A. Traina, MD; Odessa Williams, AGPCNP-BC; Latasha Jordan; Nicole Badgett

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns During the Treatment and Management of TNBC

Terry P. Mamounas, MD, MPH, FACS; Joyce O’Shaughnessy, MD; David M. Euhus, MD, FACS

Community Practice Connections™: Navigating Adjuvant Decision-Making for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Christopher R. Flowers, MD, MS, FASCO; Frederick L. Locke, MD; Kami J. Maddocks, MD; Laurie H. Sehn MD, MPH

Hot Seat™: Expert Considerations to Maximize the Clinical Benefits of Targeted Therapies in Patients With Relapsed/Refractory DLBCL

Aditya Bardia, MD, MPH; Erika P. Hamilton, MD; Komal Jhaveri, MD, FACP; Nicholas Turner, MD, PhD 

  Medical Crossfire®: Evaluating the Potential Role of Next-Generation Selective Estrogen Receptor Degraders in the ER+/HER2- Breast Cancer Treatment Paradigm

Jonathan I. Silverberg, MD, PhD, MPH, FAAD; Peck Y. Ong, MD


Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication

Edward B. Garon, MD, MS; Lyudmila Bazhenova, MD; Solange Peters, MD, PhD; Zofia Piotrowska, MD, MHS

Medical Crossfire®: Leveraging EGFR Mutation Profiles to Personalize Therapeutic Decisions in Resected and Metastatic NSCLC Settings

Ruben A. Mesa, MD, FACP ; Jamile M. Shammo, MD, FASCP, FACP ; Naveen Pemmaraju, MD 

Expert Illustrations and Commentaries™: Placing New MPN Therapies Into Context Through Illustrated Case Discussions

Robert Dreicer, MD, MS, MACP, FASCO; Tomasz Beer, MD, FACP; Scott Tagawa, MD, MS, FACP; Tanya Dorff, MD

How Guidelines and Recent Clinical Trial Data Inform the Modern-Day Treatment of Advanced Prostate Cancer

Dawn A. Laney, MS, CGC; Eric Wallace, MD, FASN

Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes

Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP; Leah Smith, MSN, APRN, FNP-BC, CNN-NP, FNKF; Catherine Wells, DNP, ACNP, CNN-NP, FNKF

Cases and Conversations: Individualizing Diabetes Care in the Management of Chronic Kidney Disease: Developing the Optimal Treatment Plan With Your Patient

John Rhodes, MD; Robert J. Sommer, MD; Christine A. Holmstedt, DO

Medical Crossfire: Optimizing Outcomes for Patients with Stroke: Secondary Prevention and Risk Reduction

Reflective Case-Based Oncology Collective™: Translating Recent Evidence to the Real-World Management of Acute Lymphoblastic Leukemia

Susanna V Ulahannan, MD, MMEd; Manish Patel, MD


Expert Illustrations & Commentaries™: The Role of B7-H3 Across Tumor Types and How It Could Impact Your Practice in the Future

Jeffrey Laurence, MD; Mitchell S. Cairo, MD; Vincent T. Ho, MD; Sonata Jodele, MD

New Perspectives in HSCT-TMA: Driving the Future of Diagnosis and Treatment

Nursing Management of Relapsed/Refractory Multiple Myeloma in an Era of Expanding Options

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Luciano J. Costa, MD, PhD; Paul Shaughnessy, MD

Optimizing ASCT in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma Through Stem Cell Mobilization Techniques

Onco-Nurse Academy™: Exploring an Advent of Targeted Therapies Across Advanced NSCLC Care and Strategies for Managing Adverse Events Associated with Treatment

Anita Afzali, MD, MPH, MHCM; Marla C. Dubinsky, MD; Christina Ha, MD, FACG, AGAF

Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes

Jane S. Davis, CRNP, DNP; Jean Colaneri, ACNP-BC, CNN-NP

Community Practice Connections™: Expert Illustrations and Commentaries: Nephrology Nurse Perspectives in Anemia in CKD

Genovefa Papanicolaou, MD; Guenther Koehne, MD, PhD; Roy F. Chemaly, MD, MPH, FIDSA, FACP; Sanjeet Dadwal, MD, FACP, FIDSA

Community Practice Connections™: Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

CAR T-Cell Therapy in Multiple Myeloma: Key Considerations for Patient Selection, Transplant, and Applying Recent Data

Evolving Paradigms in Transplant-Related CMV Prevention and Management: Setting Foundations for Improved Patient Outcomes

Burst CME: Improving Outcomes for Your Patient with Vitiligo

Elizabeth Verna, MD, MSc; Arun B. Jesudian, MD

Clinical Consultations™: Facilitating Optimal Treatment Outcomes and Multidisciplinary Care in Hepatorenal Syndrome- Acute Kidney Injury (HRS-AKI)

Burst Expert Illustrations & Commentaries™: Management Strategies for Refractory Ascites

Elizabeth Verna, MD, MSc; Lisa B. VanWagner, MD, MSc, FAST, FAHA

Advances In™ Cirrhosis: Reframing the Management of Hepatorenal Syndrome-Acute Kidney Injury: A Review of Current Strategies

Evaluating the Evolution of CKD Treatment: What’s New and How Can We Incorporate It? 

Burst Expert Illustrations & Commentaries™: Current Treatments for Esophageal Variceal Hemorrhage

Anemia of Chronic Kidney Disease: Improving Recognition and Early Treatment in the Primary Care Setting

Matthew Lunning, DO, FACP; Yi Lin, MD, PhD

Community Practice Connections™: Translating Recent Evidence on CAR T-Cell Therapy to the Real-World Management of Lymphoid Malignancies

Corey S. Cutler, MD, MPH; Catherine Lee, MD

Expert Illustrations & Commentaries™: Exploring the Rationale for Emerging Mechanistic Approaches in cGvHD

Reflective Case Based Oncology Collective™: Incorporating Novel HER2- Targeted Therapies into Treatment Algorithms Across Metastatic Breast Cancer

Reflective Case Based Oncology Collective™: Incorporating Novel Therapies into Treatment Algorithms Across Acute and Chronic GvHD

Fátima Cardoso, MD; Mario Campone, MD, PhD; Giuseppe Viale, MD, FRCPath

Tumor Board: How The Experts Approach Personalized Care Plans in ER-Positive Breast Cancer

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP

Medical Crossfire®: Multidisciplinary Discussions on the Application of Novel EGFR exon 20 Targeted Regimens for NSCLC Management

Naval G. Daver, MD; Guillermo Garcia-Manero, MD; Uma Borate, MD, MS; Jacqueline S. Garcia, MD

Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Community Practice Connections™: Optimally and Safely Integrating Novel Therapies Across the DLBCL Care Spectrum

Michael A. Choti, MD; John L. Marshall, MD; Christopher Lieu, MD; Manish A. Shah, MD

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

Leonard G. Gomella, MD, FACS; Primo N. Lara Jr, MD; Daniel P. Petrylak, MD

Community Practice Connections™: 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Charles Vega, MD, FAAFP; Sandeep Nathan, MD, MS; Maja Zaric, MD

Community Practice Connections™: Venous Thromboembolism: Patient-Centric and Guideline-Directed Strategies for Optimal Coordinated Care.

Show Me Your Care Plan! Nursing Strategies to Support Continuity of Care in the Treatment of Multiple Sclerosis

Sundar Jagannath, MD, FASCO; Nikhil Munshi, MD

Oncology Consultations™: Coordinating Care for Patients with Multiple Myeloma Between CAR T Centers of Excellence and the Oncology Community

Hope S. Rugo, MD, FASCO; Kevin Kalinsky, MD, MS; Terry P. Mamounas, MD, MPH, FACS; Sara M. Tolaney, MD, MPH

Community Practice Connections™: Individualizing Therapy for High-Risk Early-Stage Hormone Receptor-Positive Breast Cancer

Casey O’Connell, MD; Kristin Horwood, ACNP-BC, AOCNP

Patient, Provider, and Caregiver Connection™: Addressing Patient Concerns While Managing Low-to-Intermediate Risk MDS

Marc R. Bloomenstein OD, FAAO; Mile Brujic OD, FAAO

Community Practice Connections™: Utilizing Topical Treatments in Presbyopia—How Will the Paradigm Shift With an Updated Armamentarium?

Patrick I. Borgen, MD; Sara A. Hurvitz, MD, FACP; Hope S. Rugo, MD, FASCO; Debu Tripathy, MD

39th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™

Joyce O’Shaughnessy, MD; Sunil S. Badve, MD, FRCPath; Judy C. Boughey, MD; Yuan Yuan, MD, PhD

Community Practice Connections™: Testing and Utilization of Ki-67 and Other Prognostic Markers for Clinical Decision-Making in HR-Positive, HER2-Negative Breast Cancer

Charu Aggarwal, MD, MPH; Alexander Drilon, MD; Lynette M. Sholl, MD

Medical Crossfire®: Implications of Tumor Testing Results Across Advanced NSCLC Treatment

Daniel P. Petrylak, MD; Gert Attard, MD; Celestia (Tia) S. Higano, MD, FACP; Tian Zhang, MD, MHS

Cases and Conversations™: How The Experts Make Evidence-Based Treatment Decisions in Castration-Resistant Prostate Cancer

Diana Jalal, MD; Eugene E. Wright, Jr., MD

Community Practice Connections™: Anemia of Chronic Kidney Disease – Understanding the Disease to Improve Patient Outcomes

Jorge Plutzky, MD; Alison Bailey, MD, FAACVPR, FACC; Nihar R. Desai, MD, MPH; Mary P. McGowan, MD

Community Practice Connections™: Determining When and How to Integrate PCSK9 Inhibition Into Practice

Kevin Kalinsky, MD, MS; Heather L. McArthur, MD; MPH, Debu Tripathy, MD; Joyce O'Shaughnessy, MD

Community Practice Connections™: Selecting and Sequencing Therapies Across the Disease Continuum of HER2+ Breast Cancer

Anjay Rastogi, MD, PhD; Dawn Jacob Laney, MS, CGC, CCRC

Advances In Recognizing and Treating Cardiac and Renal Manifestations in Patients With Fabry Disease

Darin T. Okuda, MD, FAAN, FANA; Le H. Hua, MD, FAAN

Advances In™ Personalizing MS Management Plans: Strategies for Optimizing Long-Term Patient Outcomes in MS and Individualizing Treatment within the S1P Receptor Modulator Class

Expert Insights: Current and Future Perspectives for the Management of Neuroendocrine Neoplasms

Marc R. Bloomenstein OD, FAAO; Justin Schweitzer, OD, FAAO; Walter Whitley, OD, MBA, FAAO

Community Practice Connections™: Exploring Treatments on the Horizon in MGD-Associated Dry Eye Disease

Joyce O’Shaughnessy, MD; Heather L. McArthur, MD, MPH; Hatem Soliman, MD

Community Practice Connections™: Integrating New Treatment Options into the Management of Triple Negative Breast Cancer

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA; I. Brian Greenwell, MD; Mary Nauffal, PharmD, MS, BCOP; Jennifer K. Elder, RN, MSN, BMTCN

Clinical Conversations with the Cancer Care Team: Optimizing the Care of Patients on CAR T-Cell Therapy Through Multidisciplinary Collaboration and Patient Insights

Angela Fleischman, MD, PhD; Jill Brennan-Cook, DNP, RN-BC, CNE; Natasha Johnson, MSN, APRN, AOCNP; Sandra Kurtin, PhD, ANP-C, AOCN


Cases and Conversations™ With the Oncology Nursing Team: Making Sense of How We Treat MPNs Today and How Novel Strategies Will Shape Patient Care Tomorrow

Kelley R. Branch, MD, MSc, FACC, FSCCT; Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC

Expert Illustrations & Commentaries™: Protecting Patients with CAD and PAD from Secondary Events with Effective Antithrombotic Strategies

R. Sharon Chinthrajah, MD; Carla M. Davis, MD; and Edwin H. Kim, MD, MS

The Future of Food Allergy: Novel Treatment Options on the Horizon

Jared Weiss, MD; Michael Pulley, MD, PhD; Beth Sandy, MSN, CRNP

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

Jenny McDade Despotovic, DO; Laura Dogan, RN, BSN, CPN; Caroline Piatek, MD; Jennifer Russell, A-G NP

Medical Crossfire®: What Role Does the Onco-Nurse Play in the Care and Management of Patients With ITP?

Esen K. Akpek, MD; John D. Sheppard, MD, MMSc, FACS

Advances in™ Sjögren Syndrome-Related Dry Eye Disease: A Focus on Pathophysiology and Clinical Trials

Manesh R. Patel, MD; Marc P. Bonaca, MD, MPH, FAHA, FACC; Jorge Antonio Gutierrez, MD; Amy W. Pollak, MD, MSc, FAHA

Expert Illustrations & Commentaries Live!™: Antithrombotic Approaches to Reduce the Risk of Secondary Events in CAD and PAD

Hossein Borghaei, DO, MS; Lyudmila Bazhenova, MD; Ferdinandos Skoulidis, MD, PhD

Expanding Innovation in NSCLC Through Biomarker Testing and Efforts to Target KRAS G12C

Andre H. Goy, MD; Noopur Raje, MD; Bijal Shah, MD, MS

Community Practice Connections™: CAR T Preconference Workshop

Jorge E. Cortes, MD; Christopher R. Flowers, MD, MS, FASCO; Lori A. Leslie, MD; Sagar Lonial, MD, FACP

Community Practice Connections™: 26th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma 

Nikolai A. Podoltsev, MD, PhD; John Mascarenhas, MD

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

Debu Tripathy, MD; Aditya Bardia, MD, MPH; Claudine Isaacs, MD; Tiffany A. Traina, MD

Community Practice Connections ™: Aligning the Data With Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Vallerie V. Mclaughlin, MD; Richard N. Channick, MD

Expert Illustrations & Commentaries™: Finding the Best Path Forward in PAH Management – A Focus on NO-cGMP Signaling

Amy E. DeZern, MD, MHS; Catherine Broome, MD;  Michele P. Lambert, MD, MTR

Community Practice Connections™: Hematology Workshop: Navigating Nonmalignant Diseases in Everyday Practice 

Alan Menter, MD; Abby Van Voorhees, MD; Alice Bendix Gottlieb MD, PhD; Mark Lebwohl, MD; Marcus Zaayman, MD

Continuing Education